West Pharmaceutical Valuation
| WPS Stock | EUR 300.20 14.50 4.61% |
At this time, the company appears to be fairly valued. West Pharmaceutical maintains a prevalent Real Value of €295.88 per share. The last-minute price of the company is €300.2. Our model calculates the value of West Pharmaceutical from examining the company fundamentals such as Profit Margin of 0.20 %, return on asset of 0.14, and Current Valuation of 16.35 B as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that West Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of West Pharmaceutical is based on 3 months time horizon. Increasing West Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the West stock is determined by what a typical buyer is willing to pay for full or partial control of West Pharmaceutical Services. Since West Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of West Stock. However, West Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 300.2 | Real 295.88 | Hype 300.2 | Naive 313.4 |
The real value of West Stock, also known as its intrinsic value, is the underlying worth of West Pharmaceutical Company, which is reflected in its stock price. It is based on West Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of West Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of West Pharmaceutical Services helps investors to forecast how West stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of West Pharmaceutical more accurately as focusing exclusively on West Pharmaceutical's fundamentals will not take into account other important factors: West Pharmaceutical Total Value Analysis
West Pharmaceutical Services is at this time estimated to have takeover price of 16.35 B with market capitalization of 22.4 B, debt of 206.7 M, and cash on hands of 265.5 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the West Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
16.35 B | 22.4 B | 206.7 M | 265.5 M |
West Pharmaceutical Investor Information
About 96.0% of the company outstanding shares are owned by institutional investors. The company recorded earning per share (EPS) of 7.28. West Pharmaceutical last dividend was issued on the 24th of January 2023. The entity had 2:1 split on the 27th of September 2013. West Pharmaceutical Services is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.West Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. West Pharmaceutical has an asset utilization ratio of 79.82 percent. This implies that the Company is making €0.8 for each dollar of assets. An increasing asset utilization means that West Pharmaceutical Services is more efficient with each dollar of assets it utilizes for everyday operations.West Pharmaceutical Ownership Allocation
West Pharmaceutical Services retains a total of 74.14 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.West Pharmaceutical Profitability Analysis
The company reported the revenue of 2.89 B. Net Income was 585.9 M with profit before overhead, payroll, taxes, and interest of 1.14 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates West Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in West Pharmaceutical and how it compares across the competition.
About West Pharmaceutical Valuation
The stock valuation mechanism determines West Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of West Pharmaceutical. We calculate exposure to West Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of West Pharmaceutical's related companies.West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company was founded in 1923 and is headquartered in Exton, Pennsylvania. West Pharmaceutical operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 7600 people.
8 Steps to conduct West Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates West Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct West Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain West Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine West Pharmaceutical's revenue streams: Identify West Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research West Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish West Pharmaceutical's growth potential: Evaluate West Pharmaceutical's management, business model, and growth potential.
- Determine West Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate West Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for West Stock analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |